ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Atrophic Vaginitis Treatment Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-24X13738
Home | Market Reports | Health| Reproductive Health
Global Atrophic Vaginitis Treatment Market Research Report 2023
BUY CHAPTERS

Global Atrophic Vaginitis Treatment Market Research Report 2025

Code: QYRE-Auto-24X13738
Report
May 2025
Pages:82
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Shionogi
Duchesnay Inc.
Pantarhei Bioscience
Mithra Pharmaceuticals
AMAG Pharmaceuticals
Bayer HealthCare Pharmaceuticals Inc.
Theramex
EndoCeutics
Hormos Medical

Atrophic Vaginitis Treatment Market Size

The global market for Atrophic Vaginitis Treatment was valued at US$ 2975 million in the year 2024 and is projected to reach a revised size of US$ 5061 million by 2031, growing at a CAGR of 8.0% during the forecast period.

Atrophic Vaginitis Treatment Market

Atrophic Vaginitis Treatment Market

Vaginal atrophy (also called atrophic vaginitis) is a condition where the lining of the vagina gets drier and thinner. This results in itching, burning and pain during sex, among other symptoms. 
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Atrophic Vaginitis Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Atrophic Vaginitis Treatment.
The Atrophic Vaginitis Treatment market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Atrophic Vaginitis Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Atrophic Vaginitis Treatment manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Atrophic Vaginitis Treatment Market Report

Report Metric Details
Report Name Atrophic Vaginitis Treatment Market
Accounted market size in year US$ 2975 million
Forecasted market size in 2031 US$ 5061 million
CAGR 8.0%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Shionogi, Duchesnay, Hormos Medical, Pantarhei Bioscience, Mithra Pharmaceuticals, AMAG Pharmaceuticals, Bayer HealthCare Pharmaceuticals Inc, Theramex, Endoceutics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Atrophic Vaginitis Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Atrophic Vaginitis Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Atrophic Vaginitis Treatment Market growing?

Ans: The Atrophic Vaginitis Treatment Market witnessing a CAGR of 8.0% during the forecast period 2025-2031.

What is the Atrophic Vaginitis Treatment Market size in 2031?

Ans: The Atrophic Vaginitis Treatment Market size in 2031 will be US$ 5061 million.

Who are the main players in the Atrophic Vaginitis Treatment Market report?

Ans: The main players in the Atrophic Vaginitis Treatment Market are Shionogi, Duchesnay, Hormos Medical, Pantarhei Bioscience, Mithra Pharmaceuticals, AMAG Pharmaceuticals, Bayer HealthCare Pharmaceuticals Inc, Theramex, Endoceutics

What are the Application segmentation covered in the Atrophic Vaginitis Treatment Market report?

Ans: The Applications covered in the Atrophic Vaginitis Treatment Market report are Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

What are the Type segmentation covered in the Atrophic Vaginitis Treatment Market report?

Ans: The Types covered in the Atrophic Vaginitis Treatment Market report are Vaginal Moisturizers, Water-based Lubricants

Recommended Reports

Women's Health Drugs

Infectious Disease Treatments

General Therapeutics Market

1 Atrophic Vaginitis Treatment Market Overview
1.1 Product Definition
1.2 Atrophic Vaginitis Treatment by Type
1.2.1 Global Atrophic Vaginitis Treatment Market Value Comparison by Type (2024 VS 2031)
1.2.2 Vaginal Moisturizers
1.2.3 Water-based Lubricants
1.3 Atrophic Vaginitis Treatment by Application
1.3.1 Global Atrophic Vaginitis Treatment Market Value by Application (2024 VS 2031)
1.3.2 Hospital Pharmacy
1.3.3 Online Pharmacy
1.3.4 Retail Pharmacy
1.4 Global Atrophic Vaginitis Treatment Market Size Estimates and Forecasts
1.4.1 Global Atrophic Vaginitis Treatment Revenue 2020-2031
1.4.2 Global Atrophic Vaginitis Treatment Sales 2020-2031
1.4.3 Global Atrophic Vaginitis Treatment Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Atrophic Vaginitis Treatment Market Competition by Manufacturers
2.1 Global Atrophic Vaginitis Treatment Sales Market Share by Manufacturers (2020-2025)
2.2 Global Atrophic Vaginitis Treatment Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Atrophic Vaginitis Treatment Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Atrophic Vaginitis Treatment, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Atrophic Vaginitis Treatment, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Atrophic Vaginitis Treatment, Product Type & Application
2.7 Global Key Manufacturers of Atrophic Vaginitis Treatment, Date of Enter into This Industry
2.8 Global Atrophic Vaginitis Treatment Market Competitive Situation and Trends
2.8.1 Global Atrophic Vaginitis Treatment Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Atrophic Vaginitis Treatment Players Market Share by Revenue
2.8.3 Global Atrophic Vaginitis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Atrophic Vaginitis Treatment Market Scenario by Region
3.1 Global Atrophic Vaginitis Treatment Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Atrophic Vaginitis Treatment Sales by Region: 2020-2031
3.2.1 Global Atrophic Vaginitis Treatment Sales by Region: 2020-2025
3.2.2 Global Atrophic Vaginitis Treatment Sales by Region: 2026-2031
3.3 Global Atrophic Vaginitis Treatment Revenue by Region: 2020-2031
3.3.1 Global Atrophic Vaginitis Treatment Revenue by Region: 2020-2025
3.3.2 Global Atrophic Vaginitis Treatment Revenue by Region: 2026-2031
3.4 North America Atrophic Vaginitis Treatment Market Facts & Figures by Country
3.4.1 North America Atrophic Vaginitis Treatment Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Atrophic Vaginitis Treatment Sales by Country (2020-2031)
3.4.3 North America Atrophic Vaginitis Treatment Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Atrophic Vaginitis Treatment Market Facts & Figures by Country
3.5.1 Europe Atrophic Vaginitis Treatment Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Atrophic Vaginitis Treatment Sales by Country (2020-2031)
3.5.3 Europe Atrophic Vaginitis Treatment Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Atrophic Vaginitis Treatment Market Facts & Figures by Region
3.6.1 Asia Pacific Atrophic Vaginitis Treatment Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Atrophic Vaginitis Treatment Sales by Region (2020-2031)
3.6.3 Asia Pacific Atrophic Vaginitis Treatment Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Atrophic Vaginitis Treatment Market Facts & Figures by Country
3.7.1 Latin America Atrophic Vaginitis Treatment Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Atrophic Vaginitis Treatment Sales by Country (2020-2031)
3.7.3 Latin America Atrophic Vaginitis Treatment Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Atrophic Vaginitis Treatment Market Facts & Figures by Country
3.8.1 Middle East and Africa Atrophic Vaginitis Treatment Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Atrophic Vaginitis Treatment Sales by Country (2020-2031)
3.8.3 Middle East and Africa Atrophic Vaginitis Treatment Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Atrophic Vaginitis Treatment Sales by Type (2020-2031)
4.1.1 Global Atrophic Vaginitis Treatment Sales by Type (2020-2025)
4.1.2 Global Atrophic Vaginitis Treatment Sales by Type (2026-2031)
4.1.3 Global Atrophic Vaginitis Treatment Sales Market Share by Type (2020-2031)
4.2 Global Atrophic Vaginitis Treatment Revenue by Type (2020-2031)
4.2.1 Global Atrophic Vaginitis Treatment Revenue by Type (2020-2025)
4.2.2 Global Atrophic Vaginitis Treatment Revenue by Type (2026-2031)
4.2.3 Global Atrophic Vaginitis Treatment Revenue Market Share by Type (2020-2031)
4.3 Global Atrophic Vaginitis Treatment Price by Type (2020-2031)
5 Segment by Application
5.1 Global Atrophic Vaginitis Treatment Sales by Application (2020-2031)
5.1.1 Global Atrophic Vaginitis Treatment Sales by Application (2020-2025)
5.1.2 Global Atrophic Vaginitis Treatment Sales by Application (2026-2031)
5.1.3 Global Atrophic Vaginitis Treatment Sales Market Share by Application (2020-2031)
5.2 Global Atrophic Vaginitis Treatment Revenue by Application (2020-2031)
5.2.1 Global Atrophic Vaginitis Treatment Revenue by Application (2020-2025)
5.2.2 Global Atrophic Vaginitis Treatment Revenue by Application (2026-2031)
5.2.3 Global Atrophic Vaginitis Treatment Revenue Market Share by Application (2020-2031)
5.3 Global Atrophic Vaginitis Treatment Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Shionogi
6.1.1 Shionogi Company Information
6.1.2 Shionogi Description and Business Overview
6.1.3 Shionogi Atrophic Vaginitis Treatment Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Shionogi Atrophic Vaginitis Treatment Product Portfolio
6.1.5 Shionogi Recent Developments/Updates
6.2 Duchesnay
6.2.1 Duchesnay Company Information
6.2.2 Duchesnay Description and Business Overview
6.2.3 Duchesnay Atrophic Vaginitis Treatment Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Duchesnay Atrophic Vaginitis Treatment Product Portfolio
6.2.5 Duchesnay Recent Developments/Updates
6.3 Hormos Medical
6.3.1 Hormos Medical Company Information
6.3.2 Hormos Medical Description and Business Overview
6.3.3 Hormos Medical Atrophic Vaginitis Treatment Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Hormos Medical Atrophic Vaginitis Treatment Product Portfolio
6.3.5 Hormos Medical Recent Developments/Updates
6.4 Pantarhei Bioscience
6.4.1 Pantarhei Bioscience Company Information
6.4.2 Pantarhei Bioscience Description and Business Overview
6.4.3 Pantarhei Bioscience Atrophic Vaginitis Treatment Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Pantarhei Bioscience Atrophic Vaginitis Treatment Product Portfolio
6.4.5 Pantarhei Bioscience Recent Developments/Updates
6.5 Mithra Pharmaceuticals
6.5.1 Mithra Pharmaceuticals Company Information
6.5.2 Mithra Pharmaceuticals Description and Business Overview
6.5.3 Mithra Pharmaceuticals Atrophic Vaginitis Treatment Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Mithra Pharmaceuticals Atrophic Vaginitis Treatment Product Portfolio
6.5.5 Mithra Pharmaceuticals Recent Developments/Updates
6.6 AMAG Pharmaceuticals
6.6.1 AMAG Pharmaceuticals Company Information
6.6.2 AMAG Pharmaceuticals Description and Business Overview
6.6.3 AMAG Pharmaceuticals Atrophic Vaginitis Treatment Sales, Revenue and Gross Margin (2020-2025)
6.6.4 AMAG Pharmaceuticals Atrophic Vaginitis Treatment Product Portfolio
6.6.5 AMAG Pharmaceuticals Recent Developments/Updates
6.7 Bayer HealthCare Pharmaceuticals Inc
6.7.1 Bayer HealthCare Pharmaceuticals Inc Company Information
6.7.2 Bayer HealthCare Pharmaceuticals Inc Description and Business Overview
6.7.3 Bayer HealthCare Pharmaceuticals Inc Atrophic Vaginitis Treatment Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Bayer HealthCare Pharmaceuticals Inc Atrophic Vaginitis Treatment Product Portfolio
6.7.5 Bayer HealthCare Pharmaceuticals Inc Recent Developments/Updates
6.8 Theramex
6.8.1 Theramex Company Information
6.8.2 Theramex Description and Business Overview
6.8.3 Theramex Atrophic Vaginitis Treatment Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Theramex Atrophic Vaginitis Treatment Product Portfolio
6.8.5 Theramex Recent Developments/Updates
6.9 Endoceutics
6.9.1 Endoceutics Company Information
6.9.2 Endoceutics Description and Business Overview
6.9.3 Endoceutics Atrophic Vaginitis Treatment Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Endoceutics Atrophic Vaginitis Treatment Product Portfolio
6.9.5 Endoceutics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Atrophic Vaginitis Treatment Industry Chain Analysis
7.2 Atrophic Vaginitis Treatment Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Atrophic Vaginitis Treatment Production Mode & Process Analysis
7.4 Atrophic Vaginitis Treatment Sales and Marketing
7.4.1 Atrophic Vaginitis Treatment Sales Channels
7.4.2 Atrophic Vaginitis Treatment Distributors
7.5 Atrophic Vaginitis Treatment Customer Analysis
8 Atrophic Vaginitis Treatment Market Dynamics
8.1 Atrophic Vaginitis Treatment Industry Trends
8.2 Atrophic Vaginitis Treatment Market Drivers
8.3 Atrophic Vaginitis Treatment Market Challenges
8.4 Atrophic Vaginitis Treatment Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Shionogi
Duchesnay Inc.
Pantarhei Bioscience
Mithra Pharmaceuticals
AMAG Pharmaceuticals
Bayer HealthCare Pharmaceuticals Inc.
Theramex
EndoCeutics
Hormos Medical
List of Tables
 Table 1. Global Atrophic Vaginitis Treatment Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Atrophic Vaginitis Treatment Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Atrophic Vaginitis Treatment Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Atrophic Vaginitis Treatment Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Atrophic Vaginitis Treatment Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Atrophic Vaginitis Treatment Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Atrophic Vaginitis Treatment Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Atrophic Vaginitis Treatment Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Atrophic Vaginitis Treatment, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Atrophic Vaginitis Treatment, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Atrophic Vaginitis Treatment, Product Type & Application
 Table 12. Global Key Manufacturers of Atrophic Vaginitis Treatment, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Atrophic Vaginitis Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Atrophic Vaginitis Treatment as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Atrophic Vaginitis Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Atrophic Vaginitis Treatment Sales by Region (2020-2025) & (K Units)
 Table 18. Global Atrophic Vaginitis Treatment Sales Market Share by Region (2020-2025)
 Table 19. Global Atrophic Vaginitis Treatment Sales by Region (2026-2031) & (K Units)
 Table 20. Global Atrophic Vaginitis Treatment Sales Market Share by Region (2026-2031)
 Table 21. Global Atrophic Vaginitis Treatment Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Atrophic Vaginitis Treatment Revenue Market Share by Region (2020-2025)
 Table 23. Global Atrophic Vaginitis Treatment Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Atrophic Vaginitis Treatment Revenue Market Share by Region (2026-2031)
 Table 25. North America Atrophic Vaginitis Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Atrophic Vaginitis Treatment Sales by Country (2020-2025) & (K Units)
 Table 27. North America Atrophic Vaginitis Treatment Sales by Country (2026-2031) & (K Units)
 Table 28. North America Atrophic Vaginitis Treatment Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Atrophic Vaginitis Treatment Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Atrophic Vaginitis Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Atrophic Vaginitis Treatment Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Atrophic Vaginitis Treatment Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Atrophic Vaginitis Treatment Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Atrophic Vaginitis Treatment Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Atrophic Vaginitis Treatment Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Atrophic Vaginitis Treatment Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Atrophic Vaginitis Treatment Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Atrophic Vaginitis Treatment Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Atrophic Vaginitis Treatment Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Atrophic Vaginitis Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Atrophic Vaginitis Treatment Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Atrophic Vaginitis Treatment Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Atrophic Vaginitis Treatment Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Atrophic Vaginitis Treatment Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Atrophic Vaginitis Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Atrophic Vaginitis Treatment Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Atrophic Vaginitis Treatment Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Atrophic Vaginitis Treatment Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Atrophic Vaginitis Treatment Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Atrophic Vaginitis Treatment Sales (K Units) by Type (2020-2025)
 Table 51. Global Atrophic Vaginitis Treatment Sales (K Units) by Type (2026-2031)
 Table 52. Global Atrophic Vaginitis Treatment Sales Market Share by Type (2020-2025)
 Table 53. Global Atrophic Vaginitis Treatment Sales Market Share by Type (2026-2031)
 Table 54. Global Atrophic Vaginitis Treatment Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Atrophic Vaginitis Treatment Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Atrophic Vaginitis Treatment Revenue Market Share by Type (2020-2025)
 Table 57. Global Atrophic Vaginitis Treatment Revenue Market Share by Type (2026-2031)
 Table 58. Global Atrophic Vaginitis Treatment Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Atrophic Vaginitis Treatment Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Atrophic Vaginitis Treatment Sales (K Units) by Application (2020-2025)
 Table 61. Global Atrophic Vaginitis Treatment Sales (K Units) by Application (2026-2031)
 Table 62. Global Atrophic Vaginitis Treatment Sales Market Share by Application (2020-2025)
 Table 63. Global Atrophic Vaginitis Treatment Sales Market Share by Application (2026-2031)
 Table 64. Global Atrophic Vaginitis Treatment Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Atrophic Vaginitis Treatment Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Atrophic Vaginitis Treatment Revenue Market Share by Application (2020-2025)
 Table 67. Global Atrophic Vaginitis Treatment Revenue Market Share by Application (2026-2031)
 Table 68. Global Atrophic Vaginitis Treatment Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Atrophic Vaginitis Treatment Price (US$/Unit) by Application (2026-2031)
 Table 70. Shionogi Company Information
 Table 71. Shionogi Description and Business Overview
 Table 72. Shionogi Atrophic Vaginitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Shionogi Atrophic Vaginitis Treatment Product
 Table 74. Shionogi Recent Developments/Updates
 Table 75. Duchesnay Company Information
 Table 76. Duchesnay Description and Business Overview
 Table 77. Duchesnay Atrophic Vaginitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Duchesnay Atrophic Vaginitis Treatment Product
 Table 79. Duchesnay Recent Developments/Updates
 Table 80. Hormos Medical Company Information
 Table 81. Hormos Medical Description and Business Overview
 Table 82. Hormos Medical Atrophic Vaginitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Hormos Medical Atrophic Vaginitis Treatment Product
 Table 84. Hormos Medical Recent Developments/Updates
 Table 85. Pantarhei Bioscience Company Information
 Table 86. Pantarhei Bioscience Description and Business Overview
 Table 87. Pantarhei Bioscience Atrophic Vaginitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Pantarhei Bioscience Atrophic Vaginitis Treatment Product
 Table 89. Pantarhei Bioscience Recent Developments/Updates
 Table 90. Mithra Pharmaceuticals Company Information
 Table 91. Mithra Pharmaceuticals Description and Business Overview
 Table 92. Mithra Pharmaceuticals Atrophic Vaginitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Mithra Pharmaceuticals Atrophic Vaginitis Treatment Product
 Table 94. Mithra Pharmaceuticals Recent Developments/Updates
 Table 95. AMAG Pharmaceuticals Company Information
 Table 96. AMAG Pharmaceuticals Description and Business Overview
 Table 97. AMAG Pharmaceuticals Atrophic Vaginitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. AMAG Pharmaceuticals Atrophic Vaginitis Treatment Product
 Table 99. AMAG Pharmaceuticals Recent Developments/Updates
 Table 100. Bayer HealthCare Pharmaceuticals Inc Company Information
 Table 101. Bayer HealthCare Pharmaceuticals Inc Description and Business Overview
 Table 102. Bayer HealthCare Pharmaceuticals Inc Atrophic Vaginitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Bayer HealthCare Pharmaceuticals Inc Atrophic Vaginitis Treatment Product
 Table 104. Bayer HealthCare Pharmaceuticals Inc Recent Developments/Updates
 Table 105. Theramex Company Information
 Table 106. Theramex Description and Business Overview
 Table 107. Theramex Atrophic Vaginitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Theramex Atrophic Vaginitis Treatment Product
 Table 109. Theramex Recent Developments/Updates
 Table 110. Endoceutics Company Information
 Table 111. Endoceutics Description and Business Overview
 Table 112. Endoceutics Atrophic Vaginitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Endoceutics Atrophic Vaginitis Treatment Product
 Table 114. Endoceutics Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. Atrophic Vaginitis Treatment Distributors List
 Table 118. Atrophic Vaginitis Treatment Customers List
 Table 119. Atrophic Vaginitis Treatment Market Trends
 Table 120. Atrophic Vaginitis Treatment Market Drivers
 Table 121. Atrophic Vaginitis Treatment Market Challenges
 Table 122. Atrophic Vaginitis Treatment Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Atrophic Vaginitis Treatment
 Figure 2. Global Atrophic Vaginitis Treatment Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Atrophic Vaginitis Treatment Market Share by Type: 2024 & 2031
 Figure 4. Vaginal Moisturizers Product Picture
 Figure 5. Water-based Lubricants Product Picture
 Figure 6. Global Atrophic Vaginitis Treatment Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Atrophic Vaginitis Treatment Market Share by Application: 2024 & 2031
 Figure 8. Hospital Pharmacy
 Figure 9. Online Pharmacy
 Figure 10. Retail Pharmacy
 Figure 11. Global Atrophic Vaginitis Treatment Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Atrophic Vaginitis Treatment Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Atrophic Vaginitis Treatment Sales (2020-2031) & (K Units)
 Figure 14. Global Atrophic Vaginitis Treatment Average Price (US$/Unit) & (2020-2031)
 Figure 15. Atrophic Vaginitis Treatment Report Years Considered
 Figure 16. Atrophic Vaginitis Treatment Sales Share by Manufacturers in 2024
 Figure 17. Global Atrophic Vaginitis Treatment Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Atrophic Vaginitis Treatment Players: Market Share by Revenue in Atrophic Vaginitis Treatment in 2024
 Figure 19. Atrophic Vaginitis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Atrophic Vaginitis Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Atrophic Vaginitis Treatment Sales Market Share by Country (2020-2031)
 Figure 22. North America Atrophic Vaginitis Treatment Revenue Market Share by Country (2020-2031)
 Figure 23. United States Atrophic Vaginitis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Atrophic Vaginitis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Atrophic Vaginitis Treatment Sales Market Share by Country (2020-2031)
 Figure 26. Europe Atrophic Vaginitis Treatment Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Atrophic Vaginitis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Atrophic Vaginitis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Atrophic Vaginitis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Atrophic Vaginitis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Atrophic Vaginitis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Atrophic Vaginitis Treatment Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Atrophic Vaginitis Treatment Revenue Market Share by Region (2020-2031)
 Figure 34. China Atrophic Vaginitis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Atrophic Vaginitis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Atrophic Vaginitis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Atrophic Vaginitis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Atrophic Vaginitis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Atrophic Vaginitis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Atrophic Vaginitis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Atrophic Vaginitis Treatment Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Atrophic Vaginitis Treatment Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Atrophic Vaginitis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Atrophic Vaginitis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Atrophic Vaginitis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa Atrophic Vaginitis Treatment Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Atrophic Vaginitis Treatment Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey Atrophic Vaginitis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Atrophic Vaginitis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE Atrophic Vaginitis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of Atrophic Vaginitis Treatment by Type (2020-2031)
 Figure 52. Global Revenue Market Share of Atrophic Vaginitis Treatment by Type (2020-2031)
 Figure 53. Global Atrophic Vaginitis Treatment Price (US$/Unit) by Type (2020-2031)
 Figure 54. Global Sales Market Share of Atrophic Vaginitis Treatment by Application (2020-2031)
 Figure 55. Global Revenue Market Share of Atrophic Vaginitis Treatment by Application (2020-2031)
 Figure 56. Global Atrophic Vaginitis Treatment Price (US$/Unit) by Application (2020-2031)
 Figure 57. Atrophic Vaginitis Treatment Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Postmenopausal Vaginal Atrophy Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Vaginal Microbial Immunofluorescence Staining Solution Market Research Report 2024
Global Vaginal Immunofluorescence Staining Test Solution Market Research Report 2025
Global Vaginitis Immunofluorescence Staining Solution Market Research Report 2024
Global Vaginitis Rapid Test Kit Market Research Report 2024
Global Vaginosis Rapid Testing Market Research Report 2024
Global Postmenopausal Vaginal Atrophy Drugs Market Insights Forecast to 2030
Global Vaginitis Drug Market Research Report 2025
Global Vaginosis Drug Market Insights Forecast to 2030
Bacterial Vaginosis Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Vaginal Moisturizer Market Research Report 2024
Global Bacterial Vaginosis Therapeutics Market Insights Forecast to 2030
Global Bacterial Vaginosis Treatment Market Insights Forecast to 2030
Bacterial Vaginosis OTC Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Rectocele Treatment Market Insights Forecast to 2030
Bacterial Vaginosis Rx Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Vaginitis Automatic Detection System Market Research Report 2024
Global Women Intimate Care Product Market Insights Forecast to 2030
Vulvar and Vaginal Atrophy Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Postmenopausal Vaginal Atrophy PVA Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions